A New Hand-held Electronic Device Tool for Self-assessment of Neurological Disability: Mayo Clinic Electronic Emoji Based Neurological Impairment Status (MEBNIS)

Overview

About this study

The purpose of this study is:

  1. To develop an Emoji Based Neurological Impairment Status scale to assess the patient neurological status
  2. To determine the level of impairment in cognitive functions, mood, fatigue and ambulation by using emoji
  3. To validate the Emoji Based Neurological Impairment Status by comparing with neurological examination and current tests which were validated for cognition, mood, fatigue and ambulation

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients from both genders and all ethnic backgrounds will be allowed with no reservation.

Exclusion Criteria: 

  • Patients who do not consent to the study will be excluded despite being sequential

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Orhun Kantarci, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions